Dorsey & Whitney Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Sell |
3,500
-20
| -0.6% | -$6.57K | 0.06% | 284 |
|
|
2025
Q4 | $1.23M | Buy |
3,520
+253
| +8% | +$85.5K | 0.07% | 237 |
|
|
2025
Q3 | $1.06M | Sell |
3,267
-221
| -6% | -$68.7K | 0.06% | 271 |
|
|
2025
Q2 | $1.36M | Sell |
3,488
-102
| -3% | -$41K | 0.07% | 219 |
|
|
2025
Q1 | $1.56M | Buy |
3,590
+209
| +6% | +$83.9K | 0.09% | 198 |
|
|
2024
Q4 | $1.25M | Sell |
3,381
-154
| -4% | -$64.4K | 0.07% | 223 |
|
|
2024
Q3 | $1.84M | Buy |
3,535
+149
| +4% | +$79.6K | 0.1% | 170 |
|
|
2024
Q2 | $1.83M | Buy |
3,386
+18
| +0.5% | +$9.51K | 0.13% | 141 |
|
|
2024
Q1 | $1.75M | Sell |
3,368
-87
| -3% | -$43.3K | 0.12% | 150 |
|
|
2023
Q4 | $1.63M | Sell |
3,455
-436
| -11% | -$202K | 0.13% | 155 |
|
|
2023
Q3 | $1.69M | Sell |
3,891
-84
| -2% | -$38.1K | 0.15% | 132 |
|
|
2023
Q2 | $1.77M | Buy |
3,975
+68
| +2% | +$31.4K | 0.15% | 137 |
|
|
2023
Q1 | $1.8M | Sell |
3,907
-67
| -2% | -$31.9K | 0.16% | 132 |
|
|
2022
Q4 | $2.04M | Buy |
3,974
+164
| +4% | +$83.3K | 0.2% | 114 |
|
|
2022
Q3 | $1.73M | Sell |
3,810
-89
| -2% | -$42.6K | 0.18% | 128 |
|
|
2022
Q2 | $1.88M | Buy |
3,899
+37
| +1% | +$18.3K | 0.19% | 116 |
|
|
2022
Q1 | $1.9M | Buy |
3,862
+104
| +3% | +$47.5K | 0.17% | 126 |
|
|
2021
Q4 | $1.74M | Buy |
3,758
+724
| +24% | +$305K | 0.15% | 141 |
|
|
2021
Q3 | $1.13M | Sell |
3,034
-87
| -3% | -$33.1K | 0.1% | 175 |
|
|
2021
Q2 | $1.19M | Buy |
3,121
+91
| +3% | +$34.8K | 0.11% | 170 |
|
|
2021
Q1 | $1.09M | Sell |
3,030
-3
| -0.1% | -$965 | 0.11% | 184 |
|
|
2020
Q4 | $973K | Sell |
3,033
-2
| -0.1% | -$614 | 0.11% | 163 |
|
|
2020
Q3 | $814K | Sell |
3,035
-119
| -4% | -$32K | 0.11% | 169 |
|
|
2020
Q2 | $830K | Buy |
3,154
+41
| +1% | +$10.9K | 0.12% | 161 |
|
|
2020
Q1 | $706K | Buy |
3,113
+150
| +5% | +$40.9K | 0.12% | 158 |
|
|
2019
Q4 | $895K | Buy |
2,963
+559
| +23% | +$154K | 0.12% | 155 |
|
|
2019
Q3 | $577K | Buy |
2,404
+183
| +8% | +$50.1K | 0.09% | 194 |
|
|
2019
Q2 | $627K | Buy |
2,221
+133
| +6% | +$36.3K | 0.1% | 176 |
|
|
2019
Q1 | $600K | Sell |
2,088
-160
| -7% | -$46.3K | 0.09% | 176 |
|
|
2018
Q4 | $591K | Hold |
2,248
| – | – | 0.1% | 161 |
|
|
2018
Q3 | $616K | Buy |
2,248
+21
| +0.9% | +$5.45K | 0.1% | 171 |
|
|
2018
Q2 | $530K | Buy |
2,227
+187
| +9% | +$43.3K | 0.09% | 176 |
|
|
2018
Q1 | $449K | Sell |
2,040
-75
| -4% | -$17.6K | 0.08% | 183 |
|
|
2017
Q4 | $476K | Buy |
2,115
+340
| +19% | +$72.4K | 0.09% | 167 |
|
|
2017
Q3 | $337K | Buy |
1,775
+563
| +46% | +$107K | 0.07% | 205 |
|
|
2017
Q2 | $229K | Sell |
1,212
-425
| -26% | -$76.4K | 0.05% | 280 |
|
|
2017
Q1 | $270K | Buy |
+1,637
| New | +$260K | 0.05% | 246 |
|
|
2015
Q3 | – | Sell |
-1,439
| Closed | -$236K | – | 257 |
|
|
2015
Q2 | $236K | Buy |
+1,439
| New | +$230K | 0.06% | 209 |
|
|
2015
Q1 | – | Sell |
-1,712
| Closed | -$214K | – | 266 |
|
|
2014
Q4 | $214K | Buy |
+1,712
| New | +$212K | 0.06% | 235 |
|
Other funds holding ELV
VCM
VPM
Dorsey & Whitney Trust's ELV Position: Q1 2026 in Review
Dorsey & Whitney Trust reduced its Elevance Health (ELV) stake by 0.57% in Q1 2026, selling an estimated $6.57K and leaving 3,500 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #284.
Dorsey & Whitney Trust first reported a position in ELV in Q4 2014 and has held it in 39 quarters since. The position peaked at $2.04M in Q4 2022. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Dorsey & Whitney Trust held 3,500 shares of Elevance Health worth $1.02M as of Q1 2026.
- Dorsey & Whitney Trust sold 20 Elevance Health shares in Q1 2026, an estimated $6.57K.
- Elevance Health made up 0.06% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #284 holding.
- Dorsey & Whitney Trust first reported a position in Elevance Health in Q4 2014 and has held it in 39 quarters since.
- Dorsey & Whitney Trust's Elevance Health position peaked at $2.04M in Q4 2022.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.